NO20025883L - Tiazolidinonsalt for behandling av diabetes mellitus - Google Patents

Tiazolidinonsalt for behandling av diabetes mellitus

Info

Publication number
NO20025883L
NO20025883L NO20025883A NO20025883A NO20025883L NO 20025883 L NO20025883 L NO 20025883L NO 20025883 A NO20025883 A NO 20025883A NO 20025883 A NO20025883 A NO 20025883A NO 20025883 L NO20025883 L NO 20025883L
Authority
NO
Norway
Prior art keywords
thiazolidinone
salt
treatment
diabetes mellitus
mellitus
Prior art date
Application number
NO20025883A
Other languages
English (en)
Other versions
NO20025883D0 (no
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20025883D0 publication Critical patent/NO20025883D0/no
Publication of NO20025883L publication Critical patent/NO20025883L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO20025883A 2000-06-08 2002-12-06 Tiazolidinonsalt for behandling av diabetes mellitus NO20025883L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (2)

Publication Number Publication Date
NO20025883D0 NO20025883D0 (no) 2002-12-06
NO20025883L true NO20025883L (no) 2003-02-03

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025883A NO20025883L (no) 2000-06-08 2002-12-06 Tiazolidinonsalt for behandling av diabetes mellitus

Country Status (23)

Country Link
EP (1) EP1296980A1 (no)
JP (1) JP2003535862A (no)
KR (1) KR20030007918A (no)
CN (1) CN1443186A (no)
AP (1) AP2002002673A0 (no)
AU (1) AU2001264078A1 (no)
BG (1) BG107357A (no)
BR (1) BR0111536A (no)
CA (1) CA2411065A1 (no)
CZ (1) CZ20023966A3 (no)
DZ (1) DZ3382A1 (no)
EA (1) EA200300005A1 (no)
GB (1) GB0014006D0 (no)
HU (1) HUP0301137A3 (no)
IL (1) IL153279A0 (no)
MA (1) MA25753A1 (no)
MX (1) MXPA02012100A (no)
NO (1) NO20025883L (no)
OA (1) OA12284A (no)
PL (1) PL360592A1 (no)
SK (1) SK17142002A3 (no)
WO (1) WO2001094344A1 (no)
ZA (1) ZA200209954B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
WO2008091624A2 (en) * 2007-01-22 2008-07-31 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
WO2010021745A2 (en) * 2008-08-21 2010-02-25 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
AU2001264078A1 (en) 2001-12-17
MXPA02012100A (es) 2003-04-25
AP2002002673A0 (en) 2002-12-31
CZ20023966A3 (cs) 2003-04-16
CA2411065A1 (en) 2001-12-13
EA200300005A1 (ru) 2003-04-24
BR0111536A (pt) 2003-07-01
EP1296980A1 (en) 2003-04-02
ZA200209954B (en) 2003-10-10
WO2001094344A1 (en) 2001-12-13
SK17142002A3 (sk) 2003-10-07
IL153279A0 (en) 2003-07-06
HUP0301137A2 (hu) 2003-08-28
GB0014006D0 (en) 2000-08-02
PL360592A1 (en) 2004-09-20
NO20025883D0 (no) 2002-12-06
MA25753A1 (fr) 2003-04-01
DZ3382A1 (fr) 2001-12-13
OA12284A (en) 2003-11-10
JP2003535862A (ja) 2003-12-02
CN1443186A (zh) 2003-09-17
HUP0301137A3 (en) 2005-04-28
BG107357A (bg) 2003-08-29
KR20030007918A (ko) 2003-01-23

Similar Documents

Publication Publication Date Title
NO20020764L (no) Benzosyrederivater for behandling av diabetes mellitus
ATE344253T1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
NO20022087L (no) Fremgangsmåte for behandling av diabetes
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
NO20033203D0 (no) Terapeutiske heterocykliske forbindelser
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
HK1087103A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NO20013380D0 (no) 2-aminobenzoksazinonderivater for behandling av fedme
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
PL370818A1 (en) Dosage form for treatment of diabetes mellitus
IS6918A (is) Meðferð erfiðra æxla með notkun epóþílon afleiða
IS6917A (is) Epóþílon afleiður til meðhöndlunar erfiðra æxla
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
NO20045554L (no) Fremgangsmate for behandling av diabetes
NO20015288D0 (no) Anvendelse av makrolide forbindelser for behandling av tört öye
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
NO20033804L (no) Karbamatforbindelser for behandling av smerte
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20025883L (no) Tiazolidinonsalt for behandling av diabetes mellitus
NO20043483L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av type 1 Diabetes mellitus
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20024887L (no) FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application